Evan Roberts Sells 2,873 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,873 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the sale, the chief operating officer now directly owns 779,993 shares in the company, valued at $20,755,613.73. This trade represents a 0.37 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Stock Down 5.9 %

Shares of NYSE PHR opened at $26.75 on Friday. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The business has a fifty day moving average of $22.87 and a two-hundred day moving average of $22.62. The stock has a market cap of $1.55 billion, a PE ratio of -18.20 and a beta of 0.94.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the firm posted ($0.58) EPS. As a group, equities research analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp raised its position in Phreesia by 8.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock valued at $4,546,000 after purchasing an additional 16,614 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Phreesia by 1.0% in the second quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after buying an additional 853 shares in the last quarter. Hsbc Holdings PLC bought a new position in shares of Phreesia in the second quarter valued at about $301,000. Sei Investments Co. lifted its position in Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after buying an additional 95,058 shares in the last quarter. Finally, Ensign Peak Advisors Inc lifted its position in Phreesia by 3.2% during the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after buying an additional 700 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PHR has been the topic of several research analyst reports. Truist Financial raised their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. KeyCorp boosted their price target on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Friday. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $24.00 to $32.00 in a report on Wednesday. Finally, Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.